Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sankar D Navaneethan

Showing results (101-110 of 281) with videos related to

Pageof 29
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 23, 2018
Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRDCarl P Walther, Wolfgang C Winkelmayer, Anita Deswal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysisSankar D Navaneethan, Sagar U Nigwekar, Ashwini R Sehgal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2008
Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysisSankar D Navaneethan, Sonal Singh, Suresh Appasamy, et al.
Nephrology (Carlton, Vic.)|July 1, 2009
Weighing the evidence for treatment of chronic kidney disease mineral and bone disorderSankar D Navaneethan, Suetonia C Palmer, Martin J Schreiber, et al.
Cardiorenal Medicine|April 22, 2020
[Hospitalization and Critical Illness in Chronic Kidney Disease]Jefferson Lorenzo Triozzi, Jingbo Niu, Carl P Walther, et al.
Lancet (London, England)|February 6, 2007
Haemoglobin targets: we were wrong, time to move onGiovanni F M Strippoli, Giovanni Tognoni, Sankar D Navaneethan, et al.
The Cochrane Database of Systematic Reviews|April 29, 2024
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney diseasePatrizia Natale, Suetonia C Palmer, Sankar D Navaneethan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2013
Outcomes of patients receiving maintenance dialysis admitted over weekendsAnkit Sakhuja, Jesse D Schold, Gagan Kumar, et al.
Journal of the American Society of Nephrology : JASN|June 6, 2015
Cause-Specific Deaths in Non-Dialysis-Dependent CKDSankar D Navaneethan, Jesse D Schold, Susana Arrigain, et al.
Nephrology (Carlton, Vic.)|May 18, 2010
Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary interventionPraveen Kandula, Ravish Shah, Nishith Singh, et al.
Pageof 29

Showing results (101-110 of 281) with videos related to

Sort By:
Pageof 29
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 23, 2018
Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRDCarl P Walther, Wolfgang C Winkelmayer, Anita Deswal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysisSankar D Navaneethan, Sagar U Nigwekar, Ashwini R Sehgal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2008
Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysisSankar D Navaneethan, Sonal Singh, Suresh Appasamy, et al.
Nephrology (Carlton, Vic.)|July 1, 2009
Weighing the evidence for treatment of chronic kidney disease mineral and bone disorderSankar D Navaneethan, Suetonia C Palmer, Martin J Schreiber, et al.
Cardiorenal Medicine|April 22, 2020
[Hospitalization and Critical Illness in Chronic Kidney Disease]Jefferson Lorenzo Triozzi, Jingbo Niu, Carl P Walther, et al.
Lancet (London, England)|February 6, 2007
Haemoglobin targets: we were wrong, time to move onGiovanni F M Strippoli, Giovanni Tognoni, Sankar D Navaneethan, et al.
The Cochrane Database of Systematic Reviews|April 29, 2024
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney diseasePatrizia Natale, Suetonia C Palmer, Sankar D Navaneethan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2013
Outcomes of patients receiving maintenance dialysis admitted over weekendsAnkit Sakhuja, Jesse D Schold, Gagan Kumar, et al.
Journal of the American Society of Nephrology : JASN|June 6, 2015
Cause-Specific Deaths in Non-Dialysis-Dependent CKDSankar D Navaneethan, Jesse D Schold, Susana Arrigain, et al.
Nephrology (Carlton, Vic.)|May 18, 2010
Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary interventionPraveen Kandula, Ravish Shah, Nishith Singh, et al.
Pageof 29